Compare · AZTA vs TMO
AZTA vs TMO
Side-by-side comparison of Azenta Inc. (AZTA) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- AZTA operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $179.14B, about 173.7x AZTA ($1.03B).
- Over the past year, AZTA is down 27.3% and TMO is up 16.1% - TMO leads by 43.4 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 4 for AZTA).
- TMO has more recent analyst coverage (25 ratings vs 15 for AZTA).
- Company
- Azenta Inc.
- Thermo Fisher Scientific Inc
- Price
- $22.39-1.43%
- $482.27-2.41%
- Market cap
- $1.03B
- $179.14B
- 1M return
- +24.62%
- +6.57%
- 1Y return
- -27.31%
- +16.13%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 17
- Recent ratings
- 15
- 25
Azenta Inc.
Azenta, Inc. provides manufacturing automation solutions for the semiconductor industry, and life science sample-based services and solutions for the life sciences market worldwide. The company operates in two segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated ultra-cold storage systems and consumables, including racks, tubes, caps, plates, and foils; instruments, such as labeling, bar coding, capping, de-capping, auditing, sealing, peeling, piercing tubes, and plates. The Life Sciences Services segment offers genomic services and sample repository solutions, including on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting; and informatics provides sample intelligence software solutions, which support laboratory workflow scheduling for life science tools and instrument work cells, sample, inventory and logistics, environmental and temperature monitoring, clinical trial and consent management, and planning, data management, virtualization and visualization of sample collections. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AZTA
- SEC Form SD filed by Azenta Inc.
- Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
- Director Cornog William L bought $163,800 worth of Common (10,000 units at $16.38) (SEC Form 4)
- SVP, Gen Counsel & Secretary Starr Ephraim covered exercise/tax liability with 3,621 units of Common, decreasing direct ownership by 5% to 68,393 units (SEC Form 4) (for tax liability)
- Director Koffey Quentin was granted 5,663 shares, increasing direct ownership by 112% to 10,698 units (SEC Form 4)
- SEC Form S-8 filed by Azenta Inc.
- SEC Form 10-Q filed by Azenta Inc.
- Azenta Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
- President Multiomics Martin William E. Iii was granted 17,790 units of Common (SEC Form 4)
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)